• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Progen Pharmaceuticals Limited (PGL) - Financial and Strategic SWOT Analysis Review - Product Image

Progen Pharmaceuticals Limited (PGL) - Financial and Strategic SWOT Analysis Review

  • Published: May 2014
  • 36 pages
  • GlobalData

FEATURED COMPANIES

  • Genentech, Inc.
  • Novogen Limited
  • Rockeby Biomed Limited
  • MORE

Progen Pharmaceuticals Limited (PGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees READ MORE >

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Progen Pharmaceuticals Limited - Key Facts
Progen Pharmaceuticals Limited - Key Employees
Progen Pharmaceuticals Limited - Major Products and Services
Progen Pharmaceuticals Limited - Pharmaceutical Pipeline Products Data
Progen Pharmaceuticals Limited, Pipeline Products by Therapy Area
Progen Pharmaceuticals Limited, Pipeline Products by Development Phase
Progen Pharmaceuticals Limited - History
Progen Pharmaceuticals Limited - Company Statement
Progen Pharmaceuticals Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Progen Pharmaceuticals Limited - Business Description
Progen Pharmaceuticals Limited - SWOT Analysis
SWOT Analysis - Overview
Progen Pharmaceuticals Limited - Strengths
Strength - Innovation - Key to Success
Strength - Proprietary Technology Platforms
Strength - Strategic Collaborations
Strength - Patent Portfolio
Progen Pharmaceuticals Limited - Weaknesses
Weakness - History of Operating Losses
Weakness - Lack of Product Based Revenues
Weakness - Dissolution of Epi Pharmaceuticals Inc.
Progen Pharmaceuticals Limited - Opportunities
Opportunity - Pipeline Product portfolio
Opportunity - Growth Prospects: Oncology
Opportunity - Changing Demographics
Progen Pharmaceuticals Limited - Threats
Threat - Regulatory Pressures
Threat - Risk of Product Obsolescence
Threat - Competitive Landscape
Threat - Uncertain R&D Outcomes
Progen Pharmaceuticals Limited - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Progen Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Progen Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Progen Pharmaceuticals Limited, Recent Deals Summary
Section 5 – Company’s Recent Developments
Progen Pharmaceuticals Limited, Recent Developments
Nov 29, 2013: Progen Pharmaceuticals Announces Appointment of Director and Chair
Jul 12, 2013: Progen Pharmaceuticals Appoints Heng Hsin Tang As Acting Managing Director
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Progen Pharmaceuticals Limited, Key Facts
Progen Pharmaceuticals Limited, Key Employees
Progen Pharmaceuticals Limited, Major Products and Services
Progen Pharmaceuticals Limited, Number of Pipeline Products by Therapy Area
Progen Pharmaceuticals Limited, Number of Pipeline Products by Development Stage
Progen Pharmaceuticals Limited, Pipeline Products By Therapy Area and Development Phase
Progen Pharmaceuticals Limited, History
Progen Pharmaceuticals Limited, Subsidiaries
Progen Pharmaceuticals Limited, Key Competitors
Progen Pharmaceuticals Limited, Ratios based on current share price
Progen Pharmaceuticals Limited, Annual Ratios
Progen Pharmaceuticals Limited, Interim Ratios
Progen Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Progen Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Progen Pharmaceuticals Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Progen Pharmaceuticals Limited, Pipeline Products by Therapy Area
Progen Pharmaceuticals Limited, Pipeline Products by Development Phase
Progen Pharmaceuticals Limited, Performance Chart (2009 - 2013)
Progen Pharmaceuticals Limited, Ratio Charts
Progen Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Progen Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014

Genentech, Inc.
Novogen Limited
Rockeby Biomed Limited
Access Pharmaceuticals, Inc.
ChemGenex Pharmaceuticals Limited

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos